Stock Market 7 February 2026

SpaceX shares traded at $185 on Friday, down from a high of $225.64 earlier in the week but still well above the $135 IPO price. ARK’s purchases of SpaceX have linked Tesla and ETF flows, making it more difficult for fund holders to track their exposure. In Germany, advisers are planning to recommend tying retirement age to life expectancy and introducing a state-run capital fund, with Austria being considered as a benchmark despite inflation and gender differences complicating comparisons. AbbVie is reportedly close to acquiring Apogee Therapeutics for $10.9 billion in cash, with an announcement expected soon. The healthcare ETF XLV fell nearly 3% for the week, and biotechnology stocks remain sensitive to interest rate changes. The Financial Select Sector SPDR rose 0.4% last week, lagging the S&P 500’s 0.9% gain, while regional banks dropped about 2.2%. The Federal Reserve kept rates steady at 3.50%-3.75% but indicated a possible hike later in the year. S&P 500 industrials gained 2.6% over the four-day week, outperforming the broader market, with cheaper oil helping transport firms. The Energy Select Sector SPDR Fund fell 6.6%, tracking declines in major U.S. energy stocks, while Brent crude dropped to $80.57 a barrel. Nasdaq rose 2.4% for the week, ahead of the S&P 500, with upcoming reports from Micron and key economic data expected. MercadoLibre stock has dropped nearly 40% from its peak due to increased competition and fintech challenges in Latin America, despite a recent 49% rally from its lows.